使用链接片段策略发现一种强效的,选择性的蛋白质氨酸酸酶1B抑制剂
Bruce G Szczepankiewicz1, Gang Liu, Philip J Hajduk
1Metabolic Disease Research, Global Pharmaceutical Research and Development Organization, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, USA. bruce.szczepankiewicz@abbott.com
Journal of the American Chemical Society
|April 3, 2003
概括
研究人员开发了一种新型的小分子抑制蛋白氨酸酸酶1B (PTP1B) 抑制剂,有可能治疗II型糖尿病. 这种PTP1B抑制剂显示出高强度和选择性,提供了一个有前途的治疗策略.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白氨酸酸酶1B (PTP1B) 负面调节胰岛素受体,使其成为第二类糖尿病治疗的关键标.
- 开发用于PTP1B的小分子抑制剂对于改善胰岛素敏感性和控制糖尿病至关重要.
研究的目的:
- 识别和设计PTP1B的强效和选择性小分子抑制剂.
- 探索一种模块化药物设计方法,以向蛋白质氨酸酸酶.
主要方法:
- 利用基于NMR的查来识别初始催化位点和第二位点连接体.
- 采用理性设计将已识别的配体连接成单个分子.
- 使用X射线晶体学确认了抑制剂的结合和结合.
主要成果:
- 通过NMR查确定了PTP1B的非选择性竞争性抑制剂.
- 设计和合成了一种结合催化和第二位点连接体的链接抑制剂.
- 最终的化合物表现出高强度和对其他酸酶的选择性.
- X射线数据证实了PTP1B的催化部位与开放形状的结合.
结论:
- 一个模块化药物设计策略成功产生了强效和选择性的PTP1B抑制剂.
- 这种方法适用于开发对其他治疗相关蛋白氨酸酸酶的抑制剂.
- 开发的抑制剂通过增强胰岛素作用,显示出治疗II型糖尿病的潜力.
相关概念视频
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:


